An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the drug there before directing buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.
Several experts said the popularity for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer regulations, risking fines, legal action or imprisonment.
Service Reaction and Content Elimination
According to TikTok, the service has taken down problematic content and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and investing in strengthening compliance measures.
Digital Trading Operations
Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of weight loss, positive testimonials and detailed guides for preparing or administering at home.
After minutes of entering one community, a vendor posted WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or past usage.
Item Information and Costs
Inside these communities, messages display dark colored packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her team has already seen patients injured by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious medical dangers”.
